XNews

Claude Discovers Novel CRISPR-like Enzyme System in Phage

Anthropic announced that Claude discovered a new enzyme system called ART (Array-associated Reverse Transcriptase) in phage DNA, resembling CRISPR with repeated arrays and a reverse transcriptase. The discovery was made by 950 Claude agents analyzing DNA databases over 21 hours, consuming 2.1 million tokens. Experiments confirmed the arrays are transcribed into short RNAs, suggesting programmable potential.

Key insights

Claude Agents Independently Discover ART System in Phage DNA

Anthropic reported that Claude agents, given a broad prompt to find interesting reverse transcriptases, analyzed over 200,000 RT enzymes from DNA databases. After 21 hours and 2.1 million tokens, they identified 3,500 candidates and narrowed to 20. One agent recognized a repeated array structure, counted repeats, measured spacing, compared with known systems, and confirmed it was novel. The system, named ART, consists of a reverse transcriptase, an unknown partner gene, and a long array of repeated DNA sequences.

ART Shares Structural Features with CRISPR and May Be Programmable

The ART system has a repeated array similar to CRISPR's spacer array, which stores navigational information for programmable targeting. Experiments showed that ART's array is transcribed into a set of distinct short RNAs, hinting at a similar programmable mechanism. CRISPR pioneer Feng Zhang commented that this is a good example of AI agents contributing to biological discovery and that such arrays merit further study.

Anthropic CEO Highlights AI's Exponential Trajectory in Biology

Dario Amodei noted that AI performance in intellectual domains has gone from weak to superhuman in a few years, citing math as an example. He believes biology is on a similar exponential trend. While biology requires experimentation, humans can collaborate with AI to perform experiments and iterate. He stated that accelerating fundamental biological discoveries can speed up the entire biomedical pipeline, from drug targets to clinical trials.

Anthropic's Life Sciences Team Uses Public Tools, Open to Collaboration

The discovery was made by Anthropic's life sciences research team, formed in spring 2026. They operate a wet lab in the Bay Area at BSL-1 and BSL-2 levels, with all experiments performed by human scientists. The team uses publicly available Claude Science and Claude Code, meaning other labs can replicate the AI-assisted discovery pipeline. Anthropic is seeking research collaboration proposals and expanding its life sciences team.

ART's Function and Biotechnological Utility Remain Unknown

Anthropic acknowledged that the precise function of ART is not yet clear, nor its potential biotechnological utility. However, all previously discovered systems with similar features (repeated arrays and reverse transcriptase) have been capable of cutting, copying, or pasting DNA. A Stanford team independently described a similar but distinct RT system, suggesting this is an emerging area of discovery.

Source posts